HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation.

Abstract
The aim of this study was to elucidate the importance of three tumor markers, alpha-fetoprotein (AFP), Lens culinaris agglutinin A-reactive fraction of AFP (AFP-L3), and des-gamma-carboxy prothrombin (DCP), for detecting and predicting the recurrence of hepatocellular carcinomas (HCCs). A total of 108 patients with initial non-advanced HCC who underwent curative radiofrequency ablation (RFA) in our hospital were enrolled in this study. The effectiveness of the three tumor markers for detecting recurrence and recurrence-free survival was analyzed. Positivity of these three makers was not markedly increased at the first or second recurrence. In addition, there was no significant correlation between the initial and recurrent levels of each tumor marker. The tumor marker that was positive at the time of initial HCC was not necessarily positive at recurrence. The tumor marker levels at recurrence were not correlated with pre-ablation levels. No significant correlation was found in the tumor marker values between pre-ablation and the time of recurrence. On multivariate analysis, high AFP-L3 levels (>/=10%) were significantly predictive of recurrence-free survival. All three tumor markers should be routinely measured to detect recurrence during follow-up after RFA. Especially high AFP-L3 levels should be followed closely.
AuthorsTetsuya Beppu, Kazushi Sugimoto, Katsuya Shiraki, Masahiko Tameda, Satoko Kusagawa, Keiichiro Nojiri, Junichiro Tanaka, Norihiko Yamamoto, Yoshiyuki Takei, Haruyuki Takaki, Junji Uraki, Atsuhiro Nakatsuka, Koichiro Yamakado, Kan Takeda
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 26 Issue 3 Pg. 425-33 (Sep 2010) ISSN: 1791-244X [Electronic] Greece
PMID20664960 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
Topics
  • Aged
  • Biomarkers, Tumor (metabolism)
  • Carcinoma, Hepatocellular (diagnosis, prevention & control, surgery)
  • Catheter Ablation
  • Disease-Free Survival
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Liver Neoplasms (diagnosis, prevention & control, surgery)
  • Male
  • Middle Aged
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: